Better than expected result.
- $3.16m recurring rev for FY22 was a very good outcome.
- Would love to know the net proceed from the sale of DC unit to LMS. This has happened in FY19 from memory. Should be a cost of sales line somewhere.
- Need to be careful with cashburn. A significant increase in manufacturing and operating costs.
- Net operating cash outflow of $375k, seems good at first. However, if we taking out the non recurring revenue bit, it'll be much worse.
- $600k cash at bank, not a very strong position, especially if they burn that much money per quarter.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Better than expected result. $3.16m recurring rev for FY22 was a...
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AI1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.71M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AI1 (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online